Medikit Co Stock

Medikit Co ROE

The Return on Equity (ROE) of Medikit Co (7749.T) as of Aug 26, 2026 is 6.67 %. In the previous year, Return on Equity (ROE) was 6.96 % — a change of -4.06% (lower).

ROE

6.67 %

YoY

-4.06%

Last updated:

In 2026, Medikit Co's return on equity (ROE) was 6.67 %, a -4.06% increase from the 6.96 % ROE in the previous year.

The Medikit Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
6.46 JPY
Jan 1, 2019
6.43 JPY
Jan 1, 2020
6.85 JPY
Jan 1, 2021
6.09 JPY
Jan 1, 2022
6.54 JPY
Jan 1, 2023
6.06 JPY
Jan 1, 2024
6.96 JPY
Jan 1, 2025
6.67 JPY
The Medikit Co ROE history
YEARROEYoY
6.67 %-4.06%
6.96 %+14.83%
6.06 %-7.37%
6.54 %+7.31%
6.09 %-11.03%
6.85 %+6.46%
6.43 %-0.45%
6.46 %+2.33%
6.31 %-5.61%
6.69 %+0.96%
6.63 %+15.12%
5.76 %—
Access this data via the Eulerpool API
Get Free API Key

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Medikit Co's Return on Equity (ROE)

Medikit Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Medikit Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Medikit Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Medikit Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Medikit Co stock

Return on Equity (ROE) of Medikit Co is 6.67 % in 2026.

Return on Equity (ROE) of Medikit Co changed from 6.96 % to 6.67 %, representing a -4.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Medikit Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Medikit Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Medikit Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Medikit Co